Back to Search
FAYE JOHNSON, M.D.
M.D.
Pediatrics Physician
NPI: 1316974801Individual
Specialties, Licenses & Credentials
Pediatrics PhysicianPrimary
Pediatrics
Code: 208000000X
25MA07447900(NJ)
Research & Publications (20)
Developmental chlorpyrifos and methyl parathion exposure alters radial-arm maze performance in juvenile and adult rats.
PMID 19293373·Toxicol Sci·2009
7-preclinical
The role of environmental mercury, lead and pesticide exposure in development of amyotrophic lateral sclerosis.
PMID 19632272·Neurotoxicology·2009
7-preclinical
Are adult patients more tolerant of treatment risks than parents of juvenile patients?
PMID 18826414·Risk Anal·2009
8-other
Multiple sclerosis patients' benefit-risk preferences: serious adverse event risks versus treatment efficacy.
PMID 19444531·J Neurol·2009
8-other
Factors that affect adherence to bipolar disorder treatments: a stated-preference approach.
PMID 17515782·Med Care·2007
8-other
Abrogation of signal transducer and activator of transcription 3 reactivation after Src kinase inhibition results in synergistic antitumor effects.
PMID 17634553·Clin Cancer Res·2007
8-other
SRC family nonreceptor tyrosine kinases as molecular targets for cancer therapy.
PMID 18045060·Anticancer Agents Med Chem·2007
6-review
Women's willingness to accept perceived risks for vasomotor symptom relief.
PMID 17903080·J Womens Health (Larchmt)·2007
8-other
Rapid and reversible modulation of platelet function in man by a novel P2Y(12) ADP-receptor antagonist, INS50589.
PMID 17654304·Platelets·2007
3-trial
Crohn's disease patients' risk-benefit preferences: serious adverse event risks versus treatment efficacy.
PMID 17628557·Gastroenterology·2007
8-other
Geographical variation in surveillance strategies after curative-intent surgery for upper aerodigestive tract cancer.
PMID 16791449·Ann Surg Oncol·2006
8-other
High-risk individuals' willingness to pay for diabetes risk-reduction programs.
PMID 16732020·Diabetes Care·2006
8-other
Are chemotherapy patients' HRQoL importance weights consistent with linear scoring rules? A stated-choice approach.
PMID 16468083·Qual Life Res·2006
8-other
Phase I studies of imatinib mesylate combined with cisplatin and irinotecan in patients with small cell lung carcinoma.
PMID 16342249·Cancer·2006
3-trial
Metabolic syndrome increases endogenous carbon monoxide production to promote hypertension and endothelial dysfunction in obese Zucker rats.
PMID 16284090·Am J Physiol Regul Integr Comp Physiol·2006
7-preclinical
Induction of heparin-binding EGF-like growth factor and activation of EGF receptor in imatinib mesylate-treated squamous carcinoma cells.
PMID 15887238·J Cell Physiol·2005
8-other
Dasatinib (BMS-354825) tyrosine kinase inhibitor suppresses invasion and induces cell cycle arrest and apoptosis of head and neck squamous cell carcinoma and non-small cell lung cancer cells.
PMID 16203784·Clin Cancer Res·2005
8-other
A phase I/II study of neoadjuvant chemotherapy followed by radiation with boost chemotherapy for advanced T-stage nasopharyngeal carcinoma.
PMID 16199307·Int J Radiat Oncol Biol Phys·2005
3-trial
Singing-driven gene expression in the developing songbird brain.
PMID 16129463·Physiol Behav·2005
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 9555 SW BARNES RD STE 270
PORTLAND, OR 97225 - Phone
- (503) 297-1025
Quick Facts
- NPI
- 1316974801
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile